Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2016-03-02 Director's Dealing
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2016-03-02 English
OWNERSHIP DOCUMENT
Director's Dealing
2016-02-29 English
FORM 10-Q
Interim / Quarterly Report Q3 2016
2016-02-16 English
SC 13G/A
Major Shareholding Notification
2016-02-05 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 4, 2016, reporting the issuance of a press release announcing financial results for the fiscal quarter ended December 31, 2015. The text explicitly states that the press release is furnished as an exhibit and that the information is not deemed "filed" for certain legal purposes. The document does not contain the actual financial statements or detailed financial data but rather announces the release of such information. The length of the document is 4082 characters, which is relatively short and consistent with an announcement rather than a full report. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report announcing financial results but does not contain the full financial report itself. It is not an Earnings Release (ER) because it is a Form 8-K filing, and the actual earnings release is an exhibit, not the main content. Therefore, the appropriate classification is Regulatory Filings (RNS).
2016-02-04 English
SABBY 13G-A OCLS 1.05.16
Major Shareholding Notification
2016-01-05 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.